David M. Berman, HEAD OF R&D at Immunocore Holdings plc (IMCR), sold 36,140 shares at $40.03 ($1.4M) on 2025-11-25, disclosed to the SEC on 2025-11-26.
Scheduled sale ($1.4M) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 100 | $4K | 0.3% |
| 2 | $40.03 | 18,020 | $721K | 49.9% |
| 3 | $40.03 | 18,020 | $721K | 49.9% |
| Total | $40.03 avg | 36,140 | $1.4M | 100% |
| Filing → |
| IMCR | SELL | 2025-12-01 | $6.0M | — | Filing → |
| IMCR | SELL | 2025-10-02 | $4.4M | — | Filing → |
| IMCR | SELL | 2025-09-16 | $1.6M | — | Filing → |